Novel therapeutic strategy for intractable keloids: suppression of intracellular mechanotransduction and actin polymerization via Rho-kinase pathway inhibition
British Journal of Dermatology · 18.02.2025 · 192 (3) · 458-467
DOI: 10.1093/bjd/ljae384 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 11.10.2024. Verfasst von Sally Min und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, K…. Hauptthemen laut MEDLINE: Keloid, rho-Associated Kinases, Pyridines, Amides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: New Faculty Startup Fund from Seoul National University, Seoul National University Hospital, Korean Fund for Regenerative Medicine (KFRM).
Abstract (Originalsprache)
Background
Keloid is a dermal fibrotic disorder characterized by excessive extracellular matrix production by fibroblasts. Despite the significance of mechanostimulation in fibrotic diseases, its association with keloid pathophysiology or treatment remains unexplored.
Objectives
To investigate the role of mechanical force in keloid formation and elucidate the significance of Rho-associated coiled-coil-containing kinase 1 (ROCK1) as a mechanoresponsive target for keloid treatment.
Methods
Patient-derived keloid fibroblasts (KFs) were subjected to cyclic stretching ranging from 0% to 20% elongation using a cell-stretching system. We observed the inhibitory effects of the ROCK1 inhibitor Y27632 on KFs and keloid formation. Validation was performed using a keloid xenograft severe combined immune-deficient (SCID) mouse model.
Results
ROCK1 was overexpressed in KFs isolated from patients. Cyclic stretching induced fibroblast proliferation and actin polymerization by activating Rho/ROCK1 signalling. Treatment with Y27632 downregulated fibrotic markers reduced the migration capacity of KFs and induced extensive actin cytoskeleton remodelling. In the keloid xenograft SCID mouse model, Y27632 effectively suppressed keloid formation, mitigating inflammation and fibrosis.
Conclusions
The ROCK1 inhibitor Y27632 is a promising molecule for keloid treatment, exerting its effects through actin cytoskeleton remodelling and nuclear inhibition of fibrotic markers in keloid pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, Korea.
Förderung
- New Faculty Startup Fund from Seoul National University
- Seoul National University Hospital
- Korean Fund for Regenerative Medicine (KFRM)
- Ministry of Health and Welfare
- National Research Foundation of Korea
- Korea government
- SNUH Research Fund
Zitieren
APA
Min, S., Kim, K. M., Park, J. H., Lee, M., Hwang, J., & Park, J. U. (2025). Novel therapeutic strategy for intractable keloids: suppression of intracellular mechanotransduction and actin polymerization via Rho-kinase pathway inhibition. British Journal of Dermatology, 192(3), 458-467. https://doi.org/10.1093/bjd/ljae384
Vancouver
Min S, Kim KM, Park JH, Lee M, Hwang J, Park JU. Novel therapeutic strategy for intractable keloids: suppression of intracellular mechanotransduction and actin polymerization via Rho-kinase pathway inhibition. British Journal of Dermatology. 2025;192(3):458-467. doi:10.1093/bjd/ljae384
BibTeX
@article{Min2025,
author = {Min, Sally and Kim, Ki-Myo and Park, Jun Ho and Lee, Mihyun and Hwang, Joseph and Park, Ji-Ung},
title = {Novel therapeutic strategy for intractable keloids: suppression of intracellular mechanotransduction and actin polymerization via Rho-kinase pathway inhibition},
journal = {British Journal of Dermatology},
year = {2025},
volume = {192},
number = {3},
pages = {458--467},
doi = {10.1093/bjd/ljae384}
}
EUVIMED